Future Science Group
Browse
Supplementary figures.docx (239.47 kB)

PI3K/AKT/mTOR inhibitors plus fulvestrant for postmenopausal,advanced or metastatic HR +, HER2 - breast cancer. - Supplementary figures.docx

Download (239.47 kB)
figure
posted on 2023-07-27, 09:01 authored by Tianqi Zhang, Danni Xie, Xinhui Ye, Yinuo Wang, Xue Sun, Qingchun Zhao, Tianshu Ren

  

Supplementary Fig 1: Assessment of risk of bias in included studies.

  

Supplementary Fig 2: Funnel plot of comparison: the total population’ progression-free survive (PFS).

  

Supplementary Fig 3: Funnel plot of comparison: the PI3K pathway-activated’ progression-free survive (PFS).

  

Supplementary Fig 4: Funnel plot of comparison: the total population’ overall survive (OS).

  

Supplementary Fig 5: Funnel plot of comparison: the PI3K pathway-activated’ overall survive (OS).

  

Supplementary Fig 6: Forest plot of comparison: the total population’ objective response rate (ORR).

  

Supplementary Fig 7: Forest plot of comparison: the total population’ clinical benefit rate (CBR).

  

Supplementary Fig 8: Funnel plot of comparison: the total population’ objective response rate (ORR).

  

Supplementary Fig 9: Funnel plot of comparison: the total population’ clinical benefit rate (CBR).

  

Supplementary Fig 10: Forest plot of comparison: the total population’ grade 3-5 adverse events.

  

Supplementary Fig 11: Funnel plot of comparison: the total population’ grade 3-5 adverse events.

  

Supplementary Fig 12: Forest plot of comparison: the total population’ hyperglycemia.

 Supplementary Fig 13: Funnel plot of comparison: the total population’ hyperglycemia 

  

Supplementary Fig 14: Forest plot of comparison: the total population’ elevated ALT.

  

Supplementary Fig 15: Funnel plot of comparison: the total population’ elevated ALT.

  

Supplementary Fig 16: Forest plot of comparison: the total population’ elevated AST.

 Supplementary Fig 17: Funnel plot of comparison: the total population’ elevated AST. 

  

Supplementary Fig 18: Forest plot of comparison: the total population’ rash.

  

Supplementary Fig 19: Funnel plot of comparison: the total population’ rash.

  

Supplementary Fig 20: Forest plot of comparison: the total population’ diarrhoea.

  

Supplementary Fig 21: Funnel plot of comparison: the total population’ diarrhoea.

 Supplementary Fig 22: Forest plot of comparison: the total population’ stomatitis 

  

Supplementary Fig 23: Funnel plot of comparison: the total population’ stomatitis.

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC